- call +1-201-465-4211
- email sales@mrinsights.biz
Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene
Scope of the Report:
North America is the largest consumption place, with a consumption market share nearly 61.5% in 2017. Following North America, Asia-Pacific and Europe is the second two largest consumption places with the consumption market share of 18% and 17%, respectively.
The worldwide market for Transforming Growth Factor Beta 1 is expected to grow at a CAGR of roughly 11.3% over the next five years, will reach 1790 million US$ in 2024, from 1050 million US$ in 2019, according to a new study.
This report focuses on the Transforming Growth Factor Beta 1 in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Roche
Shionogi Ltd
Acceleron Pharma Inc
Genzyme Corp
Isarna Therapeutics GmbH
Scholar Rock
Sirnaomics Inc
Eli Lilly and Co
Formation Biologics Inc
Novartis AG
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Pirfenidone
Galunisertib
Others
Market Segment by Applications, can be divided into
IPF
Cancer
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Transforming Growth Factor Beta 1 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Transforming Growth Factor Beta 1, with price, sales, revenue and global market share of Transforming Growth Factor Beta 1 in 2017 and 2018.
Chapter 3, the Transforming Growth Factor Beta 1 competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Transforming Growth Factor Beta 1 breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Transforming Growth Factor Beta 1 market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Transforming Growth Factor Beta 1 sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Transforming Growth Factor Beta 1 Introduction
1.2 Market Analysis by Type
1.2.1 Pirfenidone
1.2.2 Galunisertib
1.2.3 Others
1.3 Market Analysis by Applications
1.3.1 IPF
1.3.2 Cancer
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Transforming Growth Factor Beta 1 Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Transforming Growth Factor Beta 1 Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Shionogi Ltd
2.2.1 Business Overview
2.2.2 Transforming Growth Factor Beta 1 Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Shionogi Ltd Transforming Growth Factor Beta 1 Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Acceleron Pharma Inc
2.3.1 Business Overview
2.3.2 Transforming Growth Factor Beta 1 Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Genzyme Corp
2.4.1 Business Overview
2.4.2 Transforming Growth Factor Beta 1 Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Genzyme Corp Transforming Growth Factor Beta 1 Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Isarna Therapeutics GmbH
2.5.1 Business Overview
2.5.2 Transforming Growth Factor Beta 1 Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Scholar Rock
2.6.1 Business Overview
2.6.2 Transforming Growth Factor Beta 1 Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Scholar Rock Transforming Growth Factor Beta 1 Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Sirnaomics Inc
2.7.1 Business Overview
2.7.2 Transforming Growth Factor Beta 1 Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Eli Lilly and Co
2.8.1 Business Overview
2.8.2 Transforming Growth Factor Beta 1 Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Formation Biologics Inc
2.9.1 Business Overview
2.9.2 Transforming Growth Factor Beta 1 Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Novartis AG
2.10.1 Business Overview
2.10.2 Transforming Growth Factor Beta 1 Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Novartis AG Transforming Growth Factor Beta 1 Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Transforming Growth Factor Beta 1 Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Transforming Growth Factor Beta 1 Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Transforming Growth Factor Beta 1 Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Transforming Growth Factor Beta 1 Manufacturer Market Share in 2018
3.3.2 Top 6 Transforming Growth Factor Beta 1 Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Transforming Growth Factor Beta 1 Market Analysis by Regions
4.1 Global Transforming Growth Factor Beta 1 Sales, Revenue and Market Share by Regions
4.1.1 Global Transforming Growth Factor Beta 1 Sales and Market Share by Regions (2014-2019)
4.1.2 Global Transforming Growth Factor Beta 1 Revenue and Market Share by Regions (2014-2019)
4.2 North America Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
4.3 Europe Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
4.5 South America Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
5 North America Transforming Growth Factor Beta 1 by Country
5.1 North America Transforming Growth Factor Beta 1 Sales, Revenue and Market Share by Country
5.1.1 North America Transforming Growth Factor Beta 1 Sales and Market Share by Country (2014-2019)
5.1.2 North America Transforming Growth Factor Beta 1 Revenue and Market Share by Country (2014-2019)
5.2 United States Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
5.3 Canada Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
5.4 Mexico Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
6 Europe Transforming Growth Factor Beta 1 by Country
6.1 Europe Transforming Growth Factor Beta 1 Sales, Revenue and Market Share by Country
6.1.1 Europe Transforming Growth Factor Beta 1 Sales and Market Share by Country (2014-2019)
6.1.2 Europe Transforming Growth Factor Beta 1 Revenue and Market Share by Country (2014-2019)
6.2 Germany Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
6.3 UK Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
6.4 France Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
6.5 Russia Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
6.6 Italy Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
7 Asia-Pacific Transforming Growth Factor Beta 1 by Country
7.1 Asia-Pacific Transforming Growth Factor Beta 1 Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Transforming Growth Factor Beta 1 Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Transforming Growth Factor Beta 1 Revenue and Market Share by Country (2014-2019)
7.2 China Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
7.3 Japan Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
7.4 Korea Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
7.5 India Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
8 South America Transforming Growth Factor Beta 1 by Country
8.1 South America Transforming Growth Factor Beta 1 Sales, Revenue and Market Share by Country
8.1.1 South America Transforming Growth Factor Beta 1 Sales and Market Share by Country (2014-2019)
8.1.2 South America Transforming Growth Factor Beta 1 Revenue and Market Share by Country (2014-2019)
8.2 Brazil Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
8.3 Argentina Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
8.4 Colombia Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
9 Middle East and Africa Transforming Growth Factor Beta 1 by Countries
9.1 Middle East and Africa Transforming Growth Factor Beta 1 Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Transforming Growth Factor Beta 1 Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Transforming Growth Factor Beta 1 Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
9.3 Turkey Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
9.4 Egypt Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
9.5 Nigeria Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
9.6 South Africa Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
10 Global Transforming Growth Factor Beta 1 Market Segment by Type
10.1 Global Transforming Growth Factor Beta 1 Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Transforming Growth Factor Beta 1 Sales and Market Share by Type (2014-2019)
10.1.2 Global Transforming Growth Factor Beta 1 Revenue and Market Share by Type (2014-2019)
10.2 Pirfenidone Sales Growth and Price
10.2.1 Global Pirfenidone Sales Growth (2014-2019)
10.2.2 Global Pirfenidone Price (2014-2019)
10.3 Galunisertib Sales Growth and Price
10.3.1 Global Galunisertib Sales Growth (2014-2019)
10.3.2 Global Galunisertib Price (2014-2019)
10.4 Others Sales Growth and Price
10.4.1 Global Others Sales Growth (2014-2019)
10.4.2 Global Others Price (2014-2019)
11 Global Transforming Growth Factor Beta 1 Market Segment by Application
11.1 Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2014-2019)
11.2 IPF Sales Growth (2014-2019)
11.3 Cancer Sales Growth (2014-2019)
11.4 Others Sales Growth (2014-2019)
12 Transforming Growth Factor Beta 1 Market Forecast (2019-2024)
12.1 Global Transforming Growth Factor Beta 1 Sales, Revenue and Growth Rate (2019-2024)
12.2 Transforming Growth Factor Beta 1 Market Forecast by Regions (2019-2024)
12.2.1 North America Transforming Growth Factor Beta 1 Market Forecast (2019-2024)
12.2.2 Europe Transforming Growth Factor Beta 1 Market Forecast (2019-2024)
12.2.3 Asia-Pacific Transforming Growth Factor Beta 1 Market Forecast (2019-2024)
12.2.4 South America Transforming Growth Factor Beta 1 Market Forecast (2019-2024)
12.2.5 Middle East and Africa Transforming Growth Factor Beta 1 Market Forecast (2019-2024)
12.3 Transforming Growth Factor Beta 1 Market Forecast by Type (2019-2024)
12.3.1 Global Transforming Growth Factor Beta 1 Sales Forecast by Type (2019-2024)
12.3.2 Global Transforming Growth Factor Beta 1 Market Share Forecast by Type (2019-2024)
12.4 Transforming Growth Factor Beta 1 Market Forecast by Application (2019-2024)
12.4.1 Global Transforming Growth Factor Beta 1 Sales Forecast by Application (2019-2024)
12.4.2 Global Transforming Growth Factor Beta 1 Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Transforming Growth Factor Beta 1 Picture
Table Product Specifications of Transforming Growth Factor Beta 1
Figure Global Sales Market Share of Transforming Growth F
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
